Christensen, King & Associates Investment Services, Inc. Outlook Therapeutics, Inc. Transaction History

Christensen, King & Associates Investment Services, Inc.

  • $203 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 08, 2024
SELL
$0.34 - $11.94 $55,622 - $1.95 Million
-163,596 Closed
0 $0
Q4 2023

Aug 08, 2024
BUY
$0.22 - $0.66 $35,991 - $107,973
163,596 New
163,596 $64.5 Million

Others Institutions Holding OTLK

# of Institutions
3
Shares Held
31.5K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.36B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Christensen, King & Associates Investment Services, Inc. Portfolio

Follow Christensen, King & Associates Investment Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Christensen, King & Associates Investment Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Christensen, King & Associates Investment Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email